The Covid-19 vaccine and other ways immigrants have impacted the pharmaceutical sector.
Immigration's contribution to Covid-19 and medicine
The creation of the Pfizer/BioNTech Covid-19 vaccine has been a major development in the global fight against the Coronavirus pandemic. As the vaccine begins to be rolled out across the UK, it has the potential to save hundreds of thousands of lives in the country and millions globally. But if it wasn’t for immigration, it may never have been created. This is because Pfizer is an American company founded by German immigrants and now headed by Greek immigrant Albert Bourla, whilst BioNTech is a German company founded by two Turkish immigrants, Ugur Sahin and Ozlem Tureci. It’s clear then that immigration has been a major contributor to the developing of a vaccine.
Immigrant contributions to the pharmaceutical sector
When we look at the way that immigration has impacted the pharmaceutical sector, it’s clear that the Covid-19 vaccine is just one example of many. In fact, we can thank immigrants for some of the biggest breakthroughs that the pharmaceutical industry has ever seen. Below are just a few examples of the immigrants who have made significant contributions to the pharmaceutical sector.